Metraipolis › archive › dc_e70fd13412dd

Efficacy of Pembrolizumab as Conversion Therapy in Deficient Mismatch Repair/Microsatellite Instability-High Metastatic Liver Colorectal Cancer Associated… — Europe PMC PMID:41439088

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41439088
DOI
10.7759/cureus.97493
License (as archived)
solo-consultazione
Archived
2026-11-08T08:21:49.812Z
SHA-256 of the archived text
7bcb5f418e35084ec37c633b76b25525f40485b29299e4d3e6298cce36f955a3
Stable URL of this page
https://metraipolis.com/documento/dc_e70fd13412dd

How to cite

Efficacy of Pembrolizumab as Conversion Therapy in Deficient Mismatch Repair/Microsatellite Instability-High Metastatic Liver Colorectal Cancer Associated… — Europe PMC PMID:41439088 — Europe PMC (en), https://europepmc.org/article/MED/41439088 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e70fd13412dd (Metraipolis archive dc_e70fd13412dd, sha256 7bcb5f418e35084ec37c633b76b25525f40485b29299e4d3e6298cce36f955a3)
BibTeX
@misc{dce70fd13412dd,
  title = {Efficacy of Pembrolizumab as Conversion Therapy in Deficient Mismatch Repair/Microsatellite Instability-High Metastatic Liver Colorectal Cancer Associated… — Europe PMC PMID:41439088},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41439088},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e70fd13412dd; sha256 7bcb5f418e35084ec37c633b76b25525f40485b29299e4d3e6298cce36f955a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41439088. Agents can read the archived copy with the MCP tool read_document.